Molecule intelOpportunity: ModerateEssential

Ipratropium Bromide

64 brands · 23 companies · product forms

ATC: R01AX03, R03BB01

Opportunity snapshot

Launch attractiveness
42
Market saturation
67
Price room
100
Regulatory risk
0
64
brands
23
companies
Rs 553.98
median price
59
price points
90.92x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 13%

Price room

Across observed sources and strengths
CheapestRs 125
MedianRs 553.98
Most expensiveRs 11,364.67
Spread90.92×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 90.92x across 59 trusted points (Rs 125.0-11364.67). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Ipratropium Bromide — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(33) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

23 canonical companies and 64 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 90.92x across 59 trusted points (Rs 125.0-11364.67). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.